Cargando…
Intravenous Injection of an AAV-PHP.B Vector Encoding Human Acid α-Glucosidase Rescues Both Muscle and CNS Defects in Murine Pompe Disease
Pompe disease, a severe and often fatal neuromuscular disorder, is caused by a deficiency of the lysosomal enzyme acid alpha-glucosidase (GAA). The disease is characterized by the accumulation of excess glycogen in the heart, skeletal muscle, and CNS. Currently approved enzyme replacement therapy or...
Autores principales: | Lim, Jeong-A, Yi, Haiqing, Gao, Fengqin, Raben, Nina, Kishnani, Priya S., Sun, Baodong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376130/ https://www.ncbi.nlm.nih.gov/pubmed/30809555 http://dx.doi.org/10.1016/j.omtm.2019.01.006 |
Ejemplares similares
-
Single and Dual Vector Gene Therapy with AAV9-PHP.B Rescues Hearing in Tmc1 Mutant Mice
por: Wu, Jason, et al.
Publicado: (2021) -
A Single Intravenous Injection of AAV-PHP.B-hNDUFS4 Ameliorates the Phenotype of Ndufs4(−/−) Mice
por: Silva-Pinheiro, Pedro, et al.
Publicado: (2020) -
Pilot Study Assessing the Impact of Intrathecal Administration of Variants AAV-PHP.B and AAV-PHP.eB on Brain Transduction in Adult Rhesus Macaques
por: Arotcarena, Marie-Laure, et al.
Publicado: (2021) -
Better Targeting, Better Efficiency for Wide-Scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP.B
por: Jackson, Kasey L., et al.
Publicado: (2016) -
Corrigendum: Better Targeting, Better Efficiency for Wide-Scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP.B
por: Jackson, Kasey L., et al.
Publicado: (2016)